Lexicon Pharmaceuticals (LXRX) FCF Margin Growth (1y) (2011 - 2026)
Lexicon Pharmaceuticals (LXRX) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 979.13 Mn | 808.47 Mn | 20.99 Mn | 339,913.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 339,913.00 |
| Dec 31, 2025 | -23,101.00 |
| Sep 30, 2025 | 291,343.00 |
| Jun 30, 2025 | 302,122.00 |
| Mar 31, 2025 | 157,498.00 |
| Dec 31, 2024 | 651,624.00 |
| Sep 30, 2024 | 2.27 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Jun 30, 2023 | 5.66 Mn |
| Dec 31, 2020 | -1.70 Mn |
| Jun 30, 2020 | -18.21 Mn |
| Mar 31, 2020 | 77,759.00 |
| Dec 31, 2019 | -12,013.00 |
| Sep 30, 2019 | 38,516.00 |
| Jun 30, 2019 | -274,714.00 |
| Mar 31, 2019 | -86,880.00 |
| Dec 31, 2018 | -5,987.00 |
| Sep 30, 2018 | -19,552.00 |
| Jun 30, 2018 | -11,357.00 |
| Mar 31, 2018 | 29,199.00 |